MMP9 and breast cancer: In the current study, in vitro 4T1 cell culture results revealed that HEGU and licoricidin directly inhibit the migration of 4T1 mammary cancer cells as well as the secretion of MMP-9 and VACM-1 (Figure 5C,D).